Comparison of Different Insulin Dosing Algorithms Using Hepatic Directed Vesicle-Insulin Lispro and Insulin Degludec
Clinical trial NCT03938740 · COMPLETED
Trial details
- NCT number
- NCT03938740
- Sponsor
- Diasome Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-18
- Primary completion
- 2019-12-06
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.